Literature DB >> 6354436

Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.

T Tsuruo.   

Abstract

Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics has been attained in vitro and in vivo by some calcium influx blockers and calmodulin inhibitors. These calcium influx blockers and calmodulin inhibitors enhance the intracellular level of vincristine and doxorubicin in tumor cells, especially in drug-resistant mouse and human tumor cells, by inhibiting their outward transport. Among tumor cell lines established from mice and humans, less sensitive tumor cells became more susceptible to vincristine by use of calcium influx blocker, and inherent resistance of tumor cell lines to vincristine has also been circumvented.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354436

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  29 in total

1.  Synergy between verapamil and other multidrug -resistance modulators in model membranes.

Authors:  Madeleine Castaing; Alain Loiseau; Athel Cornish-Bowden
Journal:  J Biosci       Date:  2007-06       Impact factor: 1.826

Review 2.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo.

Authors:  S Radel; I Bankusli; E Mayhew; Y M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz; Mirosława Pietruczuk
Journal:  Eur J Pediatr       Date:  2006-12       Impact factor: 3.183

5.  Enhancement of the cytogenetic efficacy of the antitumor agent bleomycin by the calcium and calmodulin antagonist fendiline.

Authors:  W Scheid; H Traut
Journal:  Experientia       Date:  1988-03-15

6.  Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity.

Authors:  T Yoshinari; Y Iwasawa; K Miura; I S Takahashi; T Fukuroda; K Suzuki; A Okura
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 7.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

8.  Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Mirosława Pietruczuk
Journal:  Eur J Pediatr       Date:  2006-09-22       Impact factor: 3.183

9.  Selective interactions of verapamil with anthraquinones in adriamycin-sensitive and -resistant murine and human tumour cell lines in vitro.

Authors:  E M Gibby; O Boyse; B T Hill
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors.

Authors:  F Formelli; L Cleris; R Carsana
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.